Metabolic
Adipotide
Also called FTPP, Prohibitin-targeting peptide
per administration
Only animal or lab studies exist — no human study has set an amount.
Quick start
Adipotide at a glance — the figures, plus how it's commonly run. Reference only, not medical advice.
- Typical dose
- 0.5–1 mg per administration
- How often
- Every day
- Where
- Commonly subcutaneous Sites and rotation
- Time to steady level
- ~10 hours — about five half-lives
- Storage
- Dry vial kept cold and dark; a mixed vial in the fridge at 2–8 °C. Details
A research and community reference, not medical advice. Figures are descriptive, vary between sources, and are not a recommendation for use.
Work out your draw
These numbers are a starting point — change any of them.
Vial label
Copy this into your label printer.
Published research contexts for Adipotide describe 0.5–1 mg per administration. Descriptive only, not a recommendation.
Human pharmacokinetics are not published; the figure is an order-of-magnitude estimate.
A prohibitin-targeting pro-apoptotic peptide that reduced fat mass in obese primates; its human phase 1 study was never published. No human dose-ranging data exists and circulating amounts are preclinical or community-derived, so no schedule table is shown.
Modelled level — every day
1× is the peak after a single dose.
- Steady-state peak
- 1.00× single dose
- Time to steady state
- 10hours
- Administrations
- 7/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- Barnhart KF et al., Sci Transl Med 2011;3:108ra112Adipotide reduced body weight and adiposity in obese rhesus monkeys; a preclinical primate study, not a human trial.